Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study.
Menke JR, Aypar U, Bangs CD, Cook SL, Gupta S, Hasserjian RP, Kong CS, Lin O, Long SR, Ly A, Menke JAS, Natkunam Y, Ruiz-Cordero R, Spiteri E, Ye J, Zadeh SL, Gratzinger DA. Menke JR, et al. Among authors: natkunam y. Front Oncol. 2024 Jun 6;14:1408238. doi: 10.3389/fonc.2024.1408238. eCollection 2024. Front Oncol. 2024. PMID: 38903717 Free PMC article.
Comparison of two immunohistochemical staining protocols for ALK demonstrates non-inferiority of a 5A4 clone-based protocol versus an ALK01 clone-based protocol for the diagnosis of ALK + anaplastic large cell lymphoma.
Fernandez-Pol S, Ferreira CR, Manohar V, Sanches JA, Lage LAPC, Pereira J, Zerbini MCN, Gratzinger D, Natkunam Y. Fernandez-Pol S, et al. Among authors: natkunam y. J Hematop. 2023 Mar;16(1):1-5. doi: 10.1007/s12308-023-00531-0. Epub 2023 Jan 31. J Hematop. 2023. PMID: 38175372 Free PMC article.
SATB2 expression in hematolymphoid neoplasms.
Tiu GC, Natkunam Y, Fernandez-Pol S. Tiu GC, et al. Among authors: natkunam y. J Hematop. 2023 Jun;16(2):119-122. doi: 10.1007/s12308-023-00543-w. Epub 2023 Apr 3. J Hematop. 2023. PMID: 38175442 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 39112383
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, Dickinson M, Prica A, Major A, Hendrickson PG, Hopkins D, Ng A, Casulo C, Baron J, Roberts KB, Al Kendi J, Balogh A, Ricardi U, Torka P, Specht L, De Silva R, Pickard K, Blazin LJ, Henry M, Smith CM, Halperin D, Brady J, Brennan B, Senchenko MA, Reeves M, Hoppe BS, Terezakis S, Talaulikar D, Picardi M, Kirova Y, Fergusson P, Hawkes EA, Lee D, Doo NW, Barraclough A, Cheah CY, Ku M, Hamad N, Mutsando H, Gilbertson M, Marconi T, Viiala N, Maurer MJ, Eichenauer DA, Hoppe RT; GLOW Consortium. Binkley MS, et al. J Clin Oncol. 2024 Jul 1;42(19):2271-2280. doi: 10.1200/JCO.23.01655. Epub 2024 Mar 26. J Clin Oncol. 2024. PMID: 38531001
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study.
Frank MJ, Baird JH, Kramer AM, Srinagesh HK, Patel S, Brown AK, Oak JS, Younes SF, Natkunam Y, Hamilton MP, Su YJ, Agarwal N, Chinnasamy H, Egeler E, Mavroukakis S, Feldman SA, Sahaf B, Mackall CL, Muffly L, Miklos DB; CARdinal-22 Investigator group. Frank MJ, et al. Among authors: natkunam y. Lancet. 2024 Jul 27;404(10450):353-363. doi: 10.1016/S0140-6736(24)00746-3. Epub 2024 Jul 9. Lancet. 2024. PMID: 38996463 Free article. Clinical Trial.
Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.
Toh J, Reitsma AJ, Tajima T, Younes SF, Ezeiruaku C, Jenkins KC, Peña JK, Zhao S, Wang X, Lee EYZ, Glass MC, Kalesinskas L, Ganesan A, Liang I, Pai JA, Harden JT, Vallania F, Vizcarra EA, Bhagat G, Craig FE, Swerdlow SH, Morscio J, Dierickx D, Tousseyn T, Satpathy AT, Krams SM, Natkunam Y, Khatri P, Martinez OM. Toh J, et al. Among authors: natkunam y. Cell Rep Med. 2024 Dec 17;5(12):101851. doi: 10.1016/j.xcrm.2024.101851. Epub 2024 Dec 9. Cell Rep Med. 2024. PMID: 39657667 Free article.
240 results